Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Klh-2109 Choline
2. Vhs6sc660q
3. 1321816-57-2
4. Obe2109 Choline
5. Unii-vhs6sc660q
6. Linzagolix Choline [usan]
7. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, 3-(5-((2,3-difluoro-6-methoxyphenyl)methoxy)-2-fluoro-4-methoxyphenyl)-1,2,3,4-tetrahydro-2,4-dioxothieno(3,4-d)pyrimidine-5-carboxylate (1:1)
8. Linzagolix Choline (usan)
9. Linzagolix Choline Salt
10. Linzagolix Choline [who-dd]
11. Chembl4298171
12. Dtxsid201337397
13. Bcp30450
14. Akos040747106
15. D11609
16. 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-2,4-dioxo-1h-thieno[3,4-d]pyrimidine-5-carboxylate;2-hydroxyethyl(trimethyl)azanium
Molecular Weight | 611.6 g/mol |
---|---|
Molecular Formula | C27H28F3N3O8S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 8 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 166 |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 867 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
H01CC04
ABOUT THIS PAGE
62
PharmaCompass offers a list of Linzagolix Choline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linzagolix Choline manufacturer or Linzagolix Choline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linzagolix Choline manufacturer or Linzagolix Choline supplier.
PharmaCompass also assists you with knowing the Linzagolix Choline API Price utilized in the formulation of products. Linzagolix Choline API Price is not always fixed or binding as the Linzagolix Choline Price is obtained through a variety of data sources. The Linzagolix Choline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linzagolix Choline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linzagolix Choline, including repackagers and relabelers. The FDA regulates Linzagolix Choline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linzagolix Choline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Linzagolix Choline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Linzagolix Choline supplier is an individual or a company that provides Linzagolix Choline active pharmaceutical ingredient (API) or Linzagolix Choline finished formulations upon request. The Linzagolix Choline suppliers may include Linzagolix Choline API manufacturers, exporters, distributors and traders.
click here to find a list of Linzagolix Choline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Linzagolix Choline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Linzagolix Choline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Linzagolix Choline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Linzagolix Choline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Linzagolix Choline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Linzagolix Choline suppliers with NDC on PharmaCompass.
Linzagolix Choline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linzagolix Choline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Linzagolix Choline GMP manufacturer or Linzagolix Choline GMP API supplier for your needs.
A Linzagolix Choline CoA (Certificate of Analysis) is a formal document that attests to Linzagolix Choline's compliance with Linzagolix Choline specifications and serves as a tool for batch-level quality control.
Linzagolix Choline CoA mostly includes findings from lab analyses of a specific batch. For each Linzagolix Choline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linzagolix Choline may be tested according to a variety of international standards, such as European Pharmacopoeia (Linzagolix Choline EP), Linzagolix Choline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linzagolix Choline USP).